Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy
Annals of Transplantation · 2026
DOI: 10.12659/aot.952135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Transplantation, 2026. Verfasst von Shih-Chao Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, China Medical University Hospital, Taichung City, Taiwan. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Neoplasms, Carcinoma, Hepatocellular, Neoplasm Recurrence, Local. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, China Medical University Hospital, Taichung City, Taiwan.
- Organ Transplant Center, China Medical University Hospital, Taichung City, Taiwan.
- Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung City, Taiwan.
- Department of Surgery, Asian University Hospital, Asian University, Taichung City, Taiwan.
- School of Medicine, China Medical University, Taichung City, Taiwan.
Zitieren
APA
Hsu, S. C., Chen, S. H., Chen, T. H., Hsu, W. F., Wang, H. W., Yeh, C. C., Yang, H. R., Lai, H. C., & Jeng, L. B. (2026). Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy. Annals of Transplantation. https://doi.org/10.12659/aot.952135
Vancouver
Hsu SC, Chen SH, Chen TH, Hsu WF, Wang HW, Yeh CC, et al. Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy. Annals of Transplantation. 2026. doi:10.12659/aot.952135
BibTeX
@article{Hsu2026,
author = {Hsu, Shih-Chao and Chen, Sheng-Hsien and Chen, Te-Hong and Hsu, Wei-Fan and Wang, Hung-Wei and Yeh, Chun-Chieh and Yang, Horng-Ren and Lai, Hsueh-Chou and Jeng, Long-Bin},
title = {Immune Checkpoint Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation: Safety Under an Immunosuppression-Preserving Strategy},
journal = {Annals of Transplantation},
year = {2026},
doi = {10.12659/aot.952135}
}
EUVIMED